{
  "id": 17232752,
  "title": "Novel Sarcoidosis Drug Fails to Improve Steroid Dose Reduction",
  "url": "https://urgent.news/2026/10/30/novel-sarcoidosis-drug-fails-to-improve-steroid-dose-reduction",
  "topic": "culture",
  "section": "Culture",
  "published": "2026-10-30T12:45:30.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/pulmonology/generalpulmonary/123653"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The novel immunomodulatory agent efzofitimod failed to reduce steroid use in pulmonary sarcoidosis, a phase III trial showed. Monthly infusions of the fusion protein targeting the neuropilin 2 receptor had no impact on placebo...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}